Skip to main content
. 2023 Jun 13;8(4):e01062-22. doi: 10.1128/msystems.01062-22

FIG 3.

FIG 3

Biomarker discovery analysis. Study of all-vs-all clinical groups by (A) Random forest and (B) LEfSe test. Groups are indicated to the right of the figures, AC, asymptomatic; AN, ambulatory SARS-CoV-2 negative; AP, ambulatory SARS-CoV-2 positive; HP, hospitalized; DHP, deceased patients.